Lv51
918 积分 2024-02-26 加入
First-Line Therapy For Advanced Non–Clear Cell Renal Cell Carcinoma
5天前
已完结
Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression
2个月前
已完结
Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
2个月前
已完结
O-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma
2个月前
已完结
Adrenomedullin/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis
2个月前
已完结
CircPTEN suppresses human clear cell renal carcinoma progression and resistance to mTOR inhibitors by targeting epigenetic modification
2个月前
已完结
PTPRZ1 dephosphorylates and stabilizes RNF26 to reduce the efficacy of TKIs and PD-1 blockade in ccRCC
4个月前
已完结
Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells
7个月前
已完结
Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases
1年前
已完结
The renal cell carcinoma drug market
1年前
已完结
皖公网安备34019202002308
